SILO PHARMA, INC. Diluted Shares Outstanding (Weighted Average)
SILO PHARMA, INC. (SILO) reported Diluted Shares Outstanding (Weighted Average) of 1.10 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-13
- SILO PHARMA, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 1.10M shares, a 162.40% increase year-over-year.
- SILO PHARMA, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 13.71M shares, a 205.71% increase year-over-year.
- SILO PHARMA, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 13.38M shares, a 197.96% increase year-over-year.
- SILO PHARMA, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 9.33M shares, a 116.91% increase year-over-year.
- SILO PHARMA, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 3.08M shares, a 34.83% increase from fiscal 2022.
- SILO PHARMA, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 2.28M shares, a 19.07% increase from fiscal 2021.
- SILO PHARMA, INC. weighted average number of shares outstanding, diluted for fiscal 2021 was 1.92M shares, a 97.09% decline from fiscal 2020.
- SILO PHARMA, INC. weighted average number of shares outstanding, diluted for fiscal 2020 was 65.95M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 1.10M shares 10-Q · filed 2026-08-13 | 1.01M shares 10-Q · filed 2026-08-13 | 9.40M shares derived: average of 3 quarters · filed 2026-08-13 | 9.38M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | 13.71M shares 10-Q · filed 2026-05-14 | 13.54M shares derived: average of 2 quarters · filed 2026-05-14 | 12.14M shares derived: average of 3 quarters · filed 2026-05-14 | 9.21M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | 13.38M shares derived: POS AM 12 month − 10-Q 9 month · filed 2026-04-14 | 11.36M shares derived: average of 2 quarters · filed 2026-04-14 | 7.71M shares derived: average of 3 quarters · filed 2026-08-13 | 8.38M shares POS AM · filed 2026-04-14 | ||||
| 2025-09-30 | 9.33M shares 10-Q · filed 2025-11-13 | 4.87M shares derived: average of 2 quarters · filed 2026-08-13 | 6.72M shares 10-Q · filed 2025-11-13 | 4.68M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | 418.65K shares 10-Q · filed 2026-08-13 | 6.28M shares 10-Q · filed 2025-08-13 | 359.17K shares 10-Q · filed 2026-08-13 | 5.39M shares 10-Q · filed 2025-08-13 | 3.13M shares derived: average of 3 quarters · filed 2026-08-13 | 3.42M shares derived: average of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | 4.48M shares 10-Q · filed 2026-05-14 | 4.49M shares derived: average of 2 quarters · filed 2026-05-14 | 4.43M shares derived: average of 3 quarters · filed 2026-05-14 | 4.08M shares derived: average of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | 4.49M shares derived: POS AM 12 month − 10-Q 9 month · filed 2026-04-14 | 4.40M shares derived: average of 2 quarters · filed 2026-04-14 | 3.95M shares derived: average of 3 quarters · filed 2026-04-14 | 3.68M shares POS AM · filed 2026-04-14 | ||||
| 2024-09-30 | 4.30M shares 10-Q · filed 2025-11-13 | 3.68M shares derived: average of 2 quarters · filed 2025-11-13 | 3.41M shares 10-Q · filed 2025-11-13 | 3.28M shares derived: average of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | 3.05M shares 10-Q · filed 2025-08-13 | 2.96M shares 10-Q · filed 2025-08-13 | 2.94M shares derived: average of 3 quarters · filed 2025-08-13 | 2.98M shares derived: average of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | 2.87M shares 10-Q · filed 2025-05-09 | 2.88M shares derived: average of 2 quarters · filed 2025-05-09 | 2.96M shares derived: average of 3 quarters · filed 2025-05-09 | 3.01M shares derived: average of 4 quarters · filed 2025-05-09 | ||||
| 2023-12-31 | 2.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | 3.00M shares derived: average of 2 quarters · filed 2025-03-28 | 3.05M shares derived: average of 3 quarters · filed 2025-03-28 | 3.08M shares 10-K · filed 2025-03-28 | ||||
| 2023-09-30 | 3.11M shares 10-Q · filed 2024-11-12 | 3.13M shares derived: average of 2 quarters · filed 2024-11-12 | 3.14M shares 10-Q · filed 2024-11-12 | 3.15M shares derived: average of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | 3.15M shares 10-Q · filed 2024-08-13 | 3.16M shares 10-Q · filed 2024-08-13 | 3.16M shares derived: average of 3 quarters · filed 2024-08-13 | 2.87M shares derived: average of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | 3.16M shares 10-Q · filed 2024-05-13 | 3.17M shares derived: average of 2 quarters · filed 2024-05-13 | 2.78M shares derived: average of 3 quarters · filed 2024-05-13 | 2.58M shares derived: average of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | 3.18M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | 2.59M shares derived: average of 2 quarters · filed 2024-03-25 | 2.39M shares derived: average of 3 quarters · filed 2024-03-25 | 2.28M shares 10-K · filed 2024-03-25 | ||||
| 2022-09-30 | 2.00M shares 10-Q · filed 2023-11-13 | 1.99M shares derived: average of 2 quarters · filed 2023-11-13 | 1.99M shares 10-Q · filed 2023-11-13 | 1.99M shares derived: average of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | 1.99M shares 10-Q · filed 2023-08-11 | 99.40M shares 10-Q · filed 2022-08-01 | 1.98M shares 10-Q · filed 2023-08-11 | 99.02M shares 10-Q · filed 2022-08-01 | 1.99M shares derived: average of 3 quarters · filed 2023-08-11 | 1.99M shares derived: average of 4 quarters · filed 2023-08-11 | ||
| 2022-03-31 | 1.97M shares 10-Q · filed 2023-05-12 | 98.64M shares 10-Q · filed 2022-05-13 | 1.98M shares derived: average of 2 quarters · filed 2023-05-12 | 1.99M shares derived: average of 3 quarters · filed 2023-05-12 | 25.70M shares derived: average of 4 quarters · filed 2023-05-12 | |||
| 2021-12-31 | 1.99M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | 1.99M shares derived: average of 2 quarters · filed 2023-03-24 | 33.62M shares derived: average of 3 quarters · filed 2023-03-24 | 1.92M shares 10-K · filed 2023-03-24 | 95.92M shares 10-K · filed 2022-03-28 | |||
| 2021-09-30 | 1.99M shares 10-Q · filed 2022-11-10 | 99.69M shares 10-Q · filed 2021-11-10 | 49.43M shares derived: average of 2 quarters · filed 2022-11-10 | 1.89M shares 10-Q · filed 2022-11-10 | 94.65M shares 10-Q · filed 2021-11-10 | 67.32M shares derived: average of 4 quarters · filed 2022-11-10 | ||
| 2021-06-30 | 96.86M shares 10-Q · filed 2022-08-01 | 91.03M shares 10-Q · filed 2022-08-01 | 89.09M shares derived: average of 3 quarters · filed 2022-08-01 | 87.92M shares derived: average of 4 quarters · filed 2022-08-01 | ||||
| 2021-03-31 | 85.14M shares 10-Q · filed 2022-05-13 | 85.21M shares derived: average of 2 quarters · filed 2022-05-13 | 84.95M shares derived: average of 3 quarters · filed 2022-05-13 | |||||
| 2020-12-31 | 85.28M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | 84.85M shares derived: average of 2 quarters · filed 2022-03-28 | 65.95M shares 10-K · filed 2022-03-28 | |||||
| 2020-09-30 | 84.42M shares 10-Q · filed 2021-11-10 | 59.51M shares 10-Q · filed 2021-11-10 | ||||||
| 2019-09-30 | 23.47M shares 10-Q · filed 2019-11-13 | 23.46M shares derived: average of 2 quarters · filed 2019-11-13 | 23.44M shares 10-Q · filed 2019-11-13 | 29.12M shares derived: average of 4 quarters · filed 2019-11-13 | ||||
| 2019-06-30 | 23.44M shares 10-Q · filed 2019-08-13 | 23.43M shares 10-Q · filed 2019-08-13 | 31.00M shares derived: average of 3 quarters · filed 2019-08-13 | 35.78M shares derived: average of 4 quarters · filed 2019-11-13 | ||||
| 2019-03-31 | 23.42M shares 10-Q · filed 2019-05-14 | 34.78M shares derived: average of 2 quarters · filed 2019-05-14 | 39.89M shares derived: average of 3 quarters · filed 2019-11-13 | 42.44M shares derived: average of 4 quarters · filed 2019-11-13 | ||||
| 2018-12-31 | 46.14M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-04 | 48.12M shares derived: average of 2 quarters · filed 2019-11-13 | 48.77M shares derived: average of 3 quarters · filed 2019-11-13 | 49.10M shares 10-K · filed 2019-04-04 | ||||
| 2018-09-30 | 50.10M shares 10-Q · filed 2019-11-13 | 50.09M shares derived: average of 2 quarters · filed 2019-11-13 | 50.09M shares 10-Q · filed 2019-11-13 | |||||
| 2018-06-30 | 50.08M shares 10-Q · filed 2019-08-13 | 50.08M shares 10-Q · filed 2019-08-13 | ||||||
| 2018-03-31 | 52.08M shares 10-Q · filed 2019-05-14 | |||||||
| 2017-12-31 | 52.08M shares 10-K · filed 2019-04-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |